RE:RE:RE:2020 - My takedonmayne,
I understand what you are saying. The patient count is actually doing good because the average patient life span is about 17 months. Covid has gone for a year at this time, so patients have died off. The patient count is basically flat. They receive a little more cash per patient a month because they are offering more services. They have adapted quickly. Remember when Covid ends Viemed has brought a lot of good will helping hospitals out.
I'm trying to come up with an example of how they adapted to Covid.
Ex. I went to get my car fixed and people aren't driving as much, so my garage is not open on Saturdays. Less work. The garage can't get into selling auto body parts. Viemed adapted by selling other COPD supplies very quickly. I am not thrilled how management does everything, but they seem to keep the top line up. The street gives no value for vent sales, or PPE sales, but this is going to go on. They first had revenue in March 2019 for this. It was only 1 million, but it will definitely go on for 2021.
The Shelf Registration won't dilute the stock because it only hurts themselves. Any acquisition would have to be accretive to earnings. These guys don't want to take money from themselves. Don't forget that.